주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Thursday, March 28, 2024, 16:52
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
3 Celltrion Drugs Win Tenders by Public Organizations in Peru
Michael Herh
2024.02.16 13:59
Celltrion Group Chairman Presents Group Vision to Foreign Investors in the US
Jasmine Choi
2023.09.12 17:51
Celltrion Obtains Sales Approval in Australia for Avastin Biosimilar 'Vegzelma'
Jasmine Choi
2023.09.04 22:15
Celltrion Completes Application for Stelara Biosimilar CT-P43 in Australia
Jasmine Choi
2023.09.01 15:32
Sales to keep climbing after bottoming out in 1Q23
Pyeongkuk Park
2023.05.15 16:24
Entering profit margin normalization phase on solid US prescriptions and one-off cost relief
Pyeongkuk Park
2023.04.10 17:42
Celltrion Healthcare: Sound Growth Led by Remsima SC and Yuflyma
Park Pyeong-kuk
2023.01.16 18:16
Celltrion: Better Profitability, Increase in Remsima SC Market Share
Kim Tae-hee
2022.08.09 09:41
Celltrion: 1Q22 Review: Earnings to Regain Momentum in 2H
Kim Tae-hee
2022.05.16 09:59
Celltrion: 4Q21 Review: Revenue Hits All-time Quarterly High
Kim Tae-hee
2022.02.17 10:57
Celltrion: 3Q21 Review: Earnings to Normalize in 4Q21 on Test Kit Exports
Kim Tae-hee
2021.11.11 09:52
Celltrion Healthcare: 1Q21 Review: Margin Erosion on Weaker U.S.-bound Exports
Hong Ka-hye
2021.05.18 10:31
처음
1
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기